Immunome (IMNM) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Immunome, Inc. (IMNM) is implementing eco-friendly substance synthesis, which correlates with the company's EV/EBITDA ratio in a historical context. The value of 0.00 determines the current status of the parameter. Growth is based on patent law and licensing potential. Meanwhile, robotic B-cell screening accelerates the development of targeted antibodies, optimizing operating expenses during early-stage testing.
immunome.com - analytical breakdowns and key metrics (IMNM)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
IMNM - Net Income|Future Profit Immunome, Inc.|IMNM - P/E Multiple|Future Price to Earnings Immunome, Inc.|IMNM - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunome Bio|IMNM - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Immunome|IMNM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth immunome.com|IMNM - Earnings per share growth rate in current year|Expected earnings per share growth for next year Immunome, Inc.
Initial company analysis:Immunome Corp IMNM
This metric compares the total enterprise value, including debt obligations, with its operating profit before interest, taxes, depreciation, and amortization to assess the fundamental stability of the business. Analyzing the EV/EBITDA multiple chart helps investors filter out market noise, evaluating the future potential of Immunome, Inc. (IMNM) through the lens of its strong pricing power and the uniqueness of its antibody discovery platform.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio AbCellera|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Enterprise Value to EBITDA Ratio Precigen Inc (PGEN)|Enterprise Value to EBITDA Ratio PHAR (Pharming)|EV/EBITDA Multiple Nektar Corp (NKTR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|ZBIO: Enterprise Value to Operating Income Before Depreciation|GOSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA KalVista Pharma|Septerna Corp (SEPN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Pieris Corp|SVRA (Savara Inc.) - EV/EBITDA Multiple|Company Value to EBITDA rigel.com RIGL|Enterprise Value to EBITDA Ratio ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ENGN (enGene Bio)|Total Company Value to Operating Income Before Depreciation Ratio rapt.com (RAPT)|JBIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACRS (aclaristx.com) - Enterprise Value to Operating Income Before Depreciation|KYTX: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Tiziana Life Sciences Ltd.|Enterprise Value to EBITDA Ratio CABA|Ventyx Biosciences, Inc (VTYX) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple THTX|Total Company Value to Operating Income Before Depreciation Ratio avalotx.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Eledon Pharmaceuticals, Inc. ELDN|AGEN - Enterprise Value to EBITDA Ratio|CLYM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ZURA (zurabio.com) - Enterprise Value to Operating Income Before Depreciation|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Adagene Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImageneBio|Shattuck Therapeutics - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple EQ|CNTB (connectbiopharm.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple IMUX (Immunic)|EV/EBITDA Multiple Atara Biotherapeutics, Inc. ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation XFOR (X4 Pharmaceuticals Inc.)|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Celularity|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple barinthusbio.com|Enterprise Value to EBITDA Ratio KZR (Kezar Life Sciences, Inc.)|SABS (SAB Biotherapeutics Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|Total Company Value to Operating Income Before Depreciation Ratio Enlivex Therapeutics Ltd (ENLV)|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio iBio Inc|Enterprise Value to EBITDA Ratio CARM|EV/EBITDA Multiple XTL Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|aimimmuno.com (AIM) - Company Value to EBITDA|Aditxt Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio GRI Bio Corporation GRI|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio reshapelifesciences.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to EBITDA Ratio Indaptus Therapeutics Inc (INDP)|Enterprise Value to EBITDA Ratio SCNI (Scinai)|EV/EBITDA Multiple calcimedica.com (CALI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|ALLK: Enterprise Value to Operating Income Before Depreciation|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA IGM Biosciences, Inc.|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Ocean Biomedical Corp|TCBP (TC Biopharm) - EV/EBITDA Multiple|Company Value to EBITDA thirdharmonicbio.com THRD
